Preoperative Low Prealbumin Is Associated With Recurrence in Patients With Stage II/III Gastric Cancer After Laparoscopic D2 Gastrectomy

被引:7
|
作者
Gao, Chun [1 ]
Zeng, Ci Dian Dan [1 ]
Tong, Yi Xin [1 ]
Zhu, Li [1 ]
Zhang, Sheng [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, Wuhan, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
gastric cancer; recurrence; risk factor; prealbumin; recurrence-free survival; cancer; PROGNOSTIC NUTRITIONAL INDEX; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; METASTASES; INDICATOR; SURVIVAL; COMPLICATIONS; CARCINOMA; JAPANESE; SURGERY;
D O I
10.3389/fsurg.2022.819514
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundPostoperative recurrence is associated with poor prognosis in patients with gastric cancer. This study aimed to explore predictive factors contributing to recurrence in patients with stage II/III gastric cancer after laparoscopic D2 gastrectomy. MethodsThis retrospective study was conducted at a single tertiary referral hospital. Patients diagnosed with gastric cancer who met the inclusion criteria were included in the study. The clinicopathological characteristics of the patients were collected. The patients were divided into recurrence and non-recurrence groups. The predictive factors were investigated using univariate and multivariate analyses. ResultsIn total, 462 patients were included. The incidence of recurrence was 26.4% (122/462) in all patients. The most common recurrence pattern was haematogenous recurrence. In the multivariate analysis, the independent predictive factors for recurrence were serum prealbumin level (p < 0.001), prognostic nutritional index (p = 0.001), carbohydrate antigen 19-9 (CA19-9) (p < 0.001), number of lymph node metastases (p < 0.001), signet-ring cell carcinoma (p = 0.001), tumor deposit (p = 0.001), and no/incomplete adjuvant chemotherapy (p < 0.001). ConclusionsOur findings revealed that nutritional status was an independent predictive factor for recurrence in patients with gastric cancer after D2 gastrectomy. We suggest that patients with risk factors for recurrence receive both nutritional support and intense surveillance.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Local recurrence after five years is associated with preoperative chemoradiotherapy treatment in patients diagnosed with stage II and III rectal cancer
    Marin, Gabriel
    Suarez, Javier
    Vera, Ruth
    Balen, Enrique
    Viudez, Antonio
    Mata, Elena
    INTERNATIONAL JOURNAL OF SURGERY, 2017, 44 : 15 - 20
  • [42] GASTROINTESTINAL CANCER Adjuvant chemotherapy after D2 gastrectomy for gastric cancer
    Yoshikawa, Takaki
    Sasako, Mitsuru
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (04) : 192 - 194
  • [43] Postoperative Chemoradiotherapy for Advanced Gastric Cancer after D2 Gastrectomy
    Deng, Xia
    Jin, Xiance
    Xue, Shengliu
    Zhang, Xuebang
    Su, Huafang
    Zhang, Ping
    Xie, Congying
    HEPATO-GASTROENTEROLOGY, 2014, 61 (133) : 1472 - 1477
  • [44] Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer
    Chang, J. S.
    Kim, K. H.
    Yoon, H. I.
    Hyung, W. J.
    Rha, S. Y.
    Kim, H. S.
    Lee, Y. C.
    Lim, J. S.
    Noh, S. H.
    Koom, W. S.
    BRITISH JOURNAL OF SURGERY, 2017, 104 (07) : 877 - 884
  • [45] Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
    Fuse, Nozomu
    Bando, Hideaki
    Chin, Keisho
    Ito, Seiji
    Yoshikawa, Takaki
    Tsuburaya, Akira
    Terashima, Masanori
    Kawashima, Yoshiyuki
    Fukunaga, Tetsu
    Gotoh, Masahiro
    Emi, Yasunori
    Yoshida, Kazuhiro
    Oki, Eiji
    Takahashi, Seiji
    Kuriki, Hiroshi
    Sato, Kumi
    Sasako, Mitsuru
    GASTRIC CANCER, 2017, 20 (02) : 332 - 340
  • [46] Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
    Nozomu Fuse
    Hideaki Bando
    Keisho Chin
    Seiji Ito
    Takaki Yoshikawa
    Akira Tsuburaya
    Masanori Terashima
    Yoshiyuki Kawashima
    Tetsu Fukunaga
    Masahiro Gotoh
    Yasunori Emi
    Kazuhiro Yoshida
    Eiji Oki
    Seiji Takahashi
    Hiroshi Kuriki
    Kumi Sato
    Mitsuru Sasako
    Gastric Cancer, 2017, 20 : 332 - 340
  • [47] Comparing D2 gastrectomy with D2 gastrectomy plus chemorradiotherapy as treatment for gastric cancer
    Weston, A.
    Vinholes, J.
    Andrade, M.
    Almelda, W.
    ANNALS OF ONCOLOGY, 2006, 17 : 99 - 99
  • [48] Laparoscopic D2 radical gastrectomy improves postoperative inflammation and gastric function in elderly patients with advanced gastric cancer
    Fu, Junhui
    Lin, Feng
    Zheng, Shuang
    Hong, Weiwen
    Zhang, Meng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (12): : 8695 - 8702
  • [49] Laparoscopic total gastrectomy with distal pancreatosplenectomy and D2 lymphadenectomy for advanced gastric cancer
    Ichiro Uyama
    Atsushi Sugioka
    Junko Fujita
    Yoshiyuki Komori
    Hideo Matsui
    Akitake Hasumi
    Gastric Cancer, 1999, 2 (4) : 230 - 234
  • [50] Adjuvant chemotherapy after curative D2 gastrectomy in Latin American patients with gastric cancer
    Serrano, Mariana
    Araujo, Jhajaira M.
    Pacheco, Cristian
    Macetas, Jackeline
    Blum, Mariella A.
    Carrato, Alfredo
    Ruiz, Eloy
    Berrospi, Francisco
    Luque, Carlos
    Chavez, Ivan
    Payet, Eduardo
    Taxa, Luis
    Montenegro, Paola
    ECANCERMEDICALSCIENCE, 2022, 16